Koji Hasegawa Selected Research

Anticoagulants

1/2023	Perspectives and Future Directions of Anticoagulant Therapy in Coronary Artery Disease Patients.
1/2022	10-Year Trends of Antithrombotic Therapy Status and Outcomes in Japanese Atrial Fibrillation Patients　- The Fushimi AF Registry.
11/2021	Clinical Characteristics and Outcomes of Very Elderly Patients With Atrial Fibrillation at High Bleeding Risk　- The Fushimi AF Registry.
2/2021	Direct Oral Anticoagulants in Asian Patients with Atrial Fibrillation: Consensus Recommendations by the Asian Pacific Society of Cardiology on Strategies for Thrombotic and Bleeding Risk Management.
1/2021	Long-term clinical outcomes after major bleeding in patients with atrial fibrillation: the Fushimi AF registry.
10/2020	Association of relative wall thickness of left ventricle with incidence of thromboembolism in patients with non-valvular atrial fibrillation: The Fushimi AF Registry.
2/2020	Anticoagulant Therapy for Patients with Coronavirus Disease 2019: Urgent Need for Enhanced Awareness.
11/2018	Current Status, Time Trends and Outcomes of Combination Therapy With Oral Anticoagulant and Antiplatelet Drug in Patients With Atrial Fibrillation　- The Fushimi AF Registry.
8/2017	Current Status and Outcomes of Direct Oral Anticoagulant Use in Real-World Atrial Fibrillation Patients　- Fushimi AF Registry.
1/2017	Relation of Stroke and Major Bleeding to Creatinine Clearance in Patients With Atrial Fibrillation (from the Fushimi AF Registry).

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Koji Hasegawa Research Topics

Disease

54	Heart Failure 03/2024 - 01/2002
29	Hypertrophy 02/2024 - 03/2002
18	Cardiomegaly (Heart Hypertrophy) 12/2023 - 01/2004
18	Myocardial Infarction 12/2022 - 07/2002
16	Atrial Fibrillation 01/2022 - 01/2014
14	Stroke (Strokes) 01/2022 - 05/2005
13	Fibrosis (Cirrhosis) 03/2024 - 01/2011
13	Atherosclerosis 04/2022 - 07/2010
12	Cardiovascular Diseases (Cardiovascular Disease) 05/2023 - 06/2008
12	Coronary Artery Disease (Coronary Atherosclerosis) 01/2023 - 01/2014
11	Inflammation (Inflammations) 02/2023 - 02/2007
9	Obesity 02/2023 - 05/2007
9	Hemorrhage 01/2023 - 12/2016
7	Embolism (Embolus) 11/2021 - 01/2015
7	Weight Gain 12/2019 - 01/2013
6	Neoplasms (Cancer) 12/2022 - 03/2004
6	Heart Diseases (Heart Disease) 09/2022 - 01/2004
5	Type 2 Diabetes Mellitus (MODY) 01/2022 - 07/2016
5	Hypertension (High Blood Pressure) 07/2021 - 04/2010
5	Insulin Resistance 01/2020 - 11/2008
5	Atherosclerotic Plaque (Atheroma) 01/2019 - 01/2011
5	Dyslipidemias (Dyslipidemia) 01/2015 - 01/2011
4	COVID-19 09/2022 - 02/2020
4	Ischemic Stroke 08/2021 - 10/2018
3	Fatigue 02/2024 - 06/2004
3	Tobacco Use Disorder (Nicotine Dependence) 01/2024 - 01/2013
3	Left Ventricular Dysfunction 12/2022 - 01/2015
3	Myocarditis (Carditis) 09/2022 - 09/2005
3	Chronic Renal Insufficiency 01/2022 - 12/2017
3	Diabetes Mellitus 06/2020 - 08/2016
3	Body Weight (Weight, Body) 01/2020 - 02/2012
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2020 - 06/2008
3	Abdominal Obesity 04/2019 - 11/2016
3	Ventricular Remodeling 01/2014 - 01/2002
2	Cardiotoxicity 01/2022 - 09/2010
2	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 07/2021 - 02/2021
2	Glucose Intolerance 01/2019 - 01/2010

Drug/Important Bio-Agent (IBA)

17	CurcuminIBA 09/2022 - 03/2008
14	AnticoagulantsIBA 01/2023 - 10/2009
12	Histone Acetyltransferases (Histone Acetyltransferase)IBA 05/2023 - 02/2006
12	oxidized low density lipoproteinIBA 01/2023 - 06/2008
11	Proteins (Proteins, Gene)FDA Link 04/2022 - 05/2003
9	Phenylephrine (Neo-Synephrine)FDA LinkGeneric 02/2024 - 09/2004
9	Transcription Factors (Transcription Factor)IBA 12/2016 - 05/2003
8	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 01/2010
7	LipidsIBA 09/2022 - 01/2011
6	Histones (Histone)IBA 03/2024 - 01/2020
6	Messenger RNA (mRNA)IBA 02/2024 - 04/2010
6	Biomarkers (Surrogate Marker)IBA 09/2022 - 01/2015
6	CholesterolIBA 01/2019 - 01/2011
5	LDL CholesterolIBA 01/2023 - 06/2008
5	Triglycerides (Triacylglycerol)IBA 01/2023 - 01/2011
4	AdipokinesIBA 04/2022 - 11/2008
4	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 03/2004
4	Eicosapentaenoic AcidIBA 01/2022 - 12/2012
4	Hemoglobins (Hemoglobin)IBA 11/2020 - 10/2009
4	MicroRNAs (MicroRNA)IBA 10/2018 - 08/2009
4	HDL CholesterolIBA 11/2017 - 01/2011
4	Lipoproteins (Lipoprotein)IBA 11/2016 - 06/2008
4	Insulin (Novolin)FDA Link 07/2016 - 10/2006
4	LDL Lipoproteins (beta Lipoproteins)IBA 01/2016 - 06/2008
3	Atrial Natriuretic Factor (ANF)IBA 02/2024 - 01/2002
3	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2023 - 11/2018
3	Brain Natriuretic Peptide (Natrecor)FDA Link 09/2022 - 01/2018
3	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2022 - 01/2014
3	GATA4 Transcription FactorIBA 01/2022 - 03/2002
3	SaltsIBA 07/2021 - 03/2008
3	Indicators and Reagents (Reagents)IBA 01/2021 - 06/2008
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2021 - 01/2015
3	Vascular Endothelial Growth Factor CIBA 01/2020 - 01/2011
3	Warfarin (Coumadin)FDA LinkGeneric 08/2017 - 04/2013
3	DNA (Deoxyribonucleic Acid)IBA 04/2008 - 02/2006
3	Endothelin-1 (Endothelin 1)IBA 11/2004 - 03/2002
2	Carbon MonoxideIBA 01/2024 - 01/2013
2	pro-brain natriuretic peptide (1-76)IBA 09/2022 - 01/2021
2	Docosahexaenoic AcidsIBA 01/2022 - 01/2014
2	omega-Chloroacetophenone (Mace)IBA 01/2022 - 08/2021
2	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2022 - 01/2020
2	zerumboneIBA 11/2021 - 02/2021
2	TeaIBA 11/2021 - 01/2020
2	Metformin (Glucophage)FDA LinkGeneric 10/2021 - 06/2020
2	Rosuvastatin Calcium (Crestor)FDA Link 01/2021 - 12/2016
2	pitavastatin (itavastatin)FDA Link 01/2021 - 12/2016
2	PolyphenolsIBA 11/2020 - 01/2018
2	Mitogen-Activated Protein Kinase 3IBA 11/2020 - 03/2002
2	Hypoglycemic Agents (Hypoglycemics)IBA 06/2020 - 01/2010
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 02/2020 - 01/2011
2	1,5- bis(3,5- bis(methoxymethoxy)phenyl)penta- 1,4- dien- 3- oneIBA 01/2020 - 12/2017
2	AcetyltransferasesIBA 01/2020 - 02/2006
2	Nicotine FDA Link 04/2019 - 01/2013
2	ApolipoproteinsIBA 01/2019 - 10/2018
2	Syntex adjuvant formulationIBA 10/2018 - 12/2017
2	AdiponectinIBA 01/2018 - 06/2008
2	LectinsIBA 01/2018 - 07/2010
2	CytokinesIBA 05/2017 - 09/2005

Therapy/Procedure

36	Therapeutics 02/2024 - 05/2007
7	Drug Therapy (Chemotherapy) 11/2022 - 09/2010
3	Vena Cava Filters (Inferior Vena Cava Filter) 07/2016 - 10/2009
2	Catheter Ablation 08/2021 - 12/2018
2	Ligation 12/2019 - 01/2003